References:
1. Yoshimura K, Tokunaga S, Daga H, Inoue M. Capecitabine-induced leukoencephalopathy. Intern Med . 2019;58(4):621-622. doi:10.2169/internalmedicine.0961-18
2. Bougea A, Voskou P, Kilidireas C, Andreadou E. Capecitabine Induced Multifocal Leukoencephalopathy: Do We Have Always to Switch off the Chemotherapy? Case Rep Oncol Med . 2016;2016. doi:10.1155/2016/2408269
3. Tan MBW, McAdory LE. Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts. J Radiol Case Rep . 2016;10(3):1-10. doi:10.3941/jrcr.v10i3.2686
4. Pacchiarotti I, Mazzarini L, Pellegrini P, et al. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer. Gen Hosp Psychiatry . 2007;29(5):461-463. doi:10.1016/j.genhosppsych.2007.04.007
5. Fora A, Alabsi E, Fakih M. A case of 5-fluorouracil-induced acute psychosis. Clin Colorectal Cancer . 2009;8(3):166-168. doi:10.3816/CCC.2009.n.027
6. Niemann B, Rochlitz C, Herrmann R, Pless M. Toxic encephalopathy induced by capecitabine. Oncology . 2004;66(4):331-335. doi:10.1159/000078335
7. Garg H, Prakash S, Deb KS, Chadda RK. Secondary mania following cancer chemotherapy with capecitabine. BMJ Case Rep . 2018;2018:bcr-2017-220995. doi:10.1136/bcr-2017-220995
8. Ala M. The footprint of kynurenine pathway in every cancer: a new target for chemotherapy. Eur J Pharmacol . 2021;896:173921. doi:10.1016/j.ejphar.2021.173921
9. Benedetti F, Aggio V, Pratesi ML, Greco G, Furlan R. Neuroinflammation in Bipolar Depression. Front Psychiatry . 2020;11. doi:10.3389/fpsyt.2020.00071
10. PR S. VigiAccess: Promoting public access to VigiBase. Indian J Pharmacol . 2016;48(5):606-607. doi:10.4103/0253-7613.190766
11. Ha JH, Hwang DY, Yu J, Park DH, Ryu SH. Onset of manic episode during chemotherapy with 5-fluorouracil. Psychiatry Investig . 2011;8(1):71-73. doi:10.4306/pi.2011.8.1.71
12. LN Y, SH K, SV P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord . 2018;20(2):97-170. doi:10.1111/BDI.12609
13. Chen VCH, Hsieh YH, Lin TC, et al. New use for old drugs: The protective effect of risperidone on colorectal cancer. Cancers (Basel) . 2020;12(6):1-16. doi:10.3390/cancers12061560
14. McKelvey KJ, Hudson AL, Back M, Eade T, Diakos CI. Radiation, inflammation and the immune response in cancer. Mamm Genome . 2018;29(11-12):843-865. doi:10.1007/s00335-018-9777-0
15. van den Ameele S, van Nuijs ALN, Lai FY, et al. A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder. Bipolar Disord . 2020;22(1):59-69. doi:10.1111/bdi.12814
16. Schaue D, Micewicz ED, Ratikan JA, Xie MW, Cheng G, McBride WH. Radiation and Inflammation. Semin Radiat Oncol . 2015;25(1):4-10. doi:10.1016/j.semradonc.2014.07.007
17. Mukherjee D, Krishnamurthy VB, Millett CE, et al. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder. Bipolar Disord . 2018;20(1):27-34. doi:10.1111/bdi.12529